Pharmaceutically acceptable salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9-pentaene

Abstract

The present invention relates to a pharmaceutically acceptable salt of a compound of the formula I wherein R1 R 2 , R3 and n are defined as in the specification, intermediates in the synthesis of such compound, pharmaceutical composition containing such compound and method of using such compound in the treatment of neurological and psychological disorders are claimed.